Полиоксиалканоаты: Биоразлагаемые полиэфиры нового поколения.

Polyester family

Polyhydroxyalkanoates or PHAs are polyesters produced in nature by numerous microorganisms, including through bacterial fermentation of sugars or lipids. When produced by bacteria they serve as both a source of energy and as a carbon store. More than 150 different monomers can be combined within this family to give materials with extremely different properties. These plastics are biodegradable and are used in the production of bioplastics. They can be either thermoplastic or elastomeric materials, with melting points ranging from 40 to 180 °C. The mechanical properties and biocompatibility of PHA can also be changed by blending, modifying the surface or combining PHA with other polymers, enzymes and inorganic materials, making it possible for a wider range of applications.

In the industrial production of PHA, the polyester is extracted and purified from the bacteria by optimizing the conditions of microbial fermentation of sugar, glucose, or vegetable oil. In the 1980s, Imperial Chemical Industries developed poly(3 hydroxybutyrate co 3 hydroxyvalerate) obtained via fermentation that was named "Biopol". It was sold under the name "Biopol" and distributed in the U. S. by Monsanto and later Metabolix. As raw material for the fermentation, carbohydrates such as glucose and sucrose can be used, but also vegetable oil or glycerine from biodiesel production. Researchers in industry are working on methods with which transgenic crops will be developed that express PHA synthesis routes from bacteria and so produce PHA as energy storage in their tissues. Several companies are working to develop methods of producing PHA from waste water, including Veolia subsidiary Anoxkaldnes. and start ups, Micromidas, Mango Materials, Full Cycle Bioplastics, Newlight and Paques Biomaterials. PHAs are processed mainly via injection molding, extrusion and extrusion bubbles into films and hollow bodies.

PHA polymers are thermoplastic, can be processed on conventional processing equipment, and are, depending on their composition, ductile and more or less elastic. They differ in their properties according to their chemical composition (homo or copolyester, contained hydroxy fatty acids). They are UV stable, in contrast to other bioplastics from polymers such as polylactic acid, partial ca. temperatures up to 180 °C, and show a low permeation of water. The crystallinity can lie in the range of a few to 70%. Processability, impact strength and flexibility improves with a higher percentage of valerate in the material. PHAs are soluble in halogenated solvents such chloroform, dichloromethane or dichloroethane. PHB is similar in its material properties to polypropylene (PP), has a good resistance to moisture and aroma barrier properties. Polyhydroxybutyric acid synthesized from pure PHB is relatively brittle and stiff. PHB copolymers, which may include other fatty acids such as beta hydroxyvaleric acid, may be elastic.

Due to its biodegradability and potential to create bioplastics with novel properties, much interest exists to develop the use of PHA based materials. PHA fits into the green economy as a means to create plastics from non fossil fuel sources. Furthermore, active research is being carried out for the biotransformation "upcycling" of plastic waste (e. g., polyethylene terephthalate and polyurethane) into PHA using Pseudomonas putida bacteria. A PHA copolymer called PHBV (poly(3 hydroxybutyrate co 3 hydroxyvalerate)) is less stiff and tougher, and it may be used as packaging material. In June 2005, US company Metabolix, Inc. received the US Presidential Green Chemistry Challenge Award (small business category) for their development and commercialisation of a cost effective method for manufacturing PHAs. There are potential applications for PHA produced by micro organisms medical and pharmaceutical industries, primarily due to their biodegradability. Fixation and orthopaedic applications have included sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone. lling augmentation material), adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats.